Anbio Biotechnology Class A Ordinary Shares (NNNN) — Cash Flow Reinvestment Rate
Anbio Biotechnology Class A Ordinary Shares (NNNN) has a Cash Flow Reinvestment Rate of 0.00x as of December 2024, reinvesting $1.67 (capex $1.67 ) from operating cash flow of $1.60 Million. Explore NNNN capital expenditure intensity to see what proportion of operating cash flow is directed to capital expenditures.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Anbio Biotechnology Class A Ordinary Shares Cash Flow Reinvestment Rate (2021–2024)
Historical reinvestment intensity for Anbio Biotechnology Class A Ordinary Shares across 4 annual periods. Also explore Anbio Biotechnology Class A Ordinary Sha assets under control for the complete picture of this company's asset base.
Annual Cash Flow Reinvestment Rate for Anbio Biotechnology Class A Ordinary Shares (2021–2024)
Year-by-year capital reinvestment analysis for Anbio Biotechnology Class A Ordinary Shares. For live market cap and broader valuation context, see market value of Anbio Biotechnology Class A Ordinary Sha.
| Year | Reinvestment Rate | Total Reinvested (USD) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2024 | 0.16x | $337.10K | $2.08 Million | $0.00 | ▼ -91.6% |
| 2023 | 1.93x | $1.73 Million | $898.37K | $0.00 | ▲ +460.8% |
| 2022 | 0.34x | $1.53 Million | $4.45 Million | $2.88 | — |
| 2021 | 0.00x | $0.00 | $4.18 Million | $0.00 | — |